
Journal of Medicinal Chemistry p. 3353 - 3358 (1992)
Update date:2022-07-30
Topics:
Bonnet, Pierre A.
Michel, Alain
Laurent, Florence
Sablayrolles, Claire
Rechencq, Eliane
et al.
Theophylline still occupies a dominant place in asthma therapy.Unfortunatly its adverse central nervous system (CNS) stimulant effects can dramatically limit its use, and adjustments in the dosage are often needed.We have synthesized a new series of imidazo<1,2-a>pyrazine derivatives which are much more potent bronchodilators than theophylline in vivo and do not exhibit the CNS stimulatory profile.In vitro studies on isolated rat uterus and guinea pig trachea confirm the high potentialities of these derivatives. 6-Bromo-8-(methylamino)imidazo<1,2-a>pyrazine-3-carbonitrile (23) is identified as the most potent compound of the series.As i n the case of theophylline, phosphodiesterase inhibition appears unlikely to be the unique mechanism of the action of this series of heterocycles.
View MoreZhuhai Rundu Pharmaceutical co.,Ltd
Contact:+86-756-7630755
Address:No.6,North Airport Road,Sanzao Town,Jinwan District
Melone Pharmaceutical Co., ltd
Contact:+86-411 82593920, 82593631
Address:No 232, JInma Roda, Development Zone, Dalian, China
Springchem New Material Technology Co.,Limited
website:http://www.spring-chem.com
Contact:86-21-62885108
Address:602B, Building 1, No. 641, Tianshan Road
Shandong Xiangde Biotechnology Co., Ltd
Contact:+86 -15066639877
Address:Sanba street
Shanghai Gsyn Chemical Co.,Ltd.
Contact:86-021-67158290
Address:86-021-67158291
Doi:10.1016/j.bmcl.2012.12.010
(2013)Doi:10.1016/j.bioorg.2018.09.028
(2018)Doi:10.3390/molecules21030232
(2016)Doi:10.1016/0009-2614(84)85547-5
(1984)Doi:10.1016/j.ejmech.2021.113244
(2021)Doi:10.1007/BF00473973
(1990)